Aytu Biopharma (AYTU) Other Working Capital Changes (2014 - 2026)

Aytu Biopharma (AYTU) has 7 years of Other Working Capital Changes data on file, last reported at -$165000.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 236.73% year-over-year to -$165000.0 in Q1 2026; TTM through Mar 2026 was -$923000.0, a 197.74% decrease from a year earlier, with the FY2025 full-year figure at -$528000.0, up 86.11% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$165000.0, up from -$182000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for AYTU reached as high as $2.8 million in Q4 2022 and fell as low as -$4.4 million in Q2 2023.
• Historically, Other Working Capital Changes has averaged -$146000.0 across 5 years, with a median of -$484000.0 in 2025.
• On a YoY basis, Other Working Capital Changes climbed as much as 13861.54% in 2023 and fell as far as 11245.45% in 2023.
• Year by year, Other Working Capital Changes stood at $109000.0 in 2022, then slumped by 155.96% to -$61000.0 in 2023, then sank by 236.07% to -$205000.0 in 2024, then rose by 11.22% to -$182000.0 in 2025, then grew by 9.34% to -$165000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$165000.0 in Q1 2026, -$182000.0 in Q4 2025, and -$403000.0 in Q3 2025.